These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 32101725)

  • 1. Glioblastoma Stem Cells: Driving Resilience through Chaos.
    Prager BC; Bhargava S; Mahadev V; Hubert CG; Rich JN
    Trends Cancer; 2020 Mar; 6(3):223-235. PubMed ID: 32101725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.
    Gimple RC; Bhargava S; Dixit D; Rich JN
    Genes Dev; 2019 Jun; 33(11-12):591-609. PubMed ID: 31160393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma.
    Biserova K; Jakovlevs A; Uljanovs R; Strumfa I
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma.
    Aderetti DA; Hira VVV; Molenaar RJ; van Noorden CJF
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):346-354. PubMed ID: 29684521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell signature in glioblastoma: therapeutic development for a moving target.
    Nakano I
    J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy.
    Pollak J; Rai KG; Funk CC; Arora S; Lee E; Zhu J; Price ND; Paddison PJ; Ramirez JM; Rostomily RC
    PLoS One; 2017; 12(3):e0172884. PubMed ID: 28264064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic strategies targeting glioblastoma stem cells.
    Carrasco-Garcia E; Sampron N; Aldaz P; Arrizabalaga O; Villanua J; Barrena C; Ruiz I; Arrazola M; Lawrie C; Matheu A
    Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):216-27. PubMed ID: 23607282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioma Stem Cell-Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling.
    Gimple RC; Kidwell RL; Kim LJY; Sun T; Gromovsky AD; Wu Q; Wolf M; Lv D; Bhargava S; Jiang L; Prager BC; Wang X; Ye Q; Zhu Z; Zhang G; Dong Z; Zhao L; Lee D; Bi J; Sloan AE; Mischel PS; Brown JM; Cang H; Huan T; Mack SC; Xie Q; Rich JN
    Cancer Discov; 2019 Sep; 9(9):1248-1267. PubMed ID: 31201181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion.
    Gangoso E; Southgate B; Bradley L; Rus S; Galvez-Cancino F; McGivern N; Güç E; Kapourani CA; Byron A; Ferguson KM; Alfazema N; Morrison G; Grant V; Blin C; Sou I; Marques-Torrejon MA; Conde L; Parrinello S; Herrero J; Beck S; Brandner S; Brennan PM; Bertone P; Pollard JW; Quezada SA; Sproul D; Frame MC; Serrels A; Pollard SM
    Cell; 2021 Apr; 184(9):2454-2470.e26. PubMed ID: 33857425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting role of glioma stem cells for glioblastoma multiforme.
    Zhang X; Zhang W; Mao XG; Zhen HN; Cao WD; Hu SJ
    Curr Med Chem; 2013; 20(15):1974-84. PubMed ID: 23317162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dynamics of Interactions Among Immune and Glioblastoma Cells.
    Eder K; Kalman B
    Neuromolecular Med; 2015 Dec; 17(4):335-52. PubMed ID: 26224516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
    Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD
    Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells.
    Guerriero C; Matera C; Del Bufalo D; De Amici M; Conti L; Dallanoce C; Tata AM
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
    Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma.
    Johnston MJ; Nikolic A; Ninkovic N; Guilhamon P; Cavalli FMG; Seaman S; Zemp FJ; Lee J; Abdelkareem A; Ellestad K; Murison A; Kushida MM; Coutinho FJ; Ma Y; Mungall AJ; Moore R; Marra MA; Taylor MD; Dirks PB; Pugh TJ; Morrissy S; St Croix B; Mahoney DJ; Lupien M; Gallo M
    Genome Res; 2019 Aug; 29(8):1211-1222. PubMed ID: 31249064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells.
    Qiu Z; Zhao L; Shen JZ; Liang Z; Wu Q; Yang K; Min L; Gimple RC; Yang Q; Bhargava S; Jin C; Kim C; Hinz D; Dixit D; Bernatchez JA; Prager BC; Zhang G; Dong Z; Lv D; Wang X; Kim LJY; Zhu Z; Jones KA; Zheng Y; Wang X; Siqueira-Neto JL; Chavez L; Fu XD; Spruck C; Rich JN
    Cancer Discov; 2022 Feb; 12(2):502-521. PubMed ID: 34615656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma Stem Cells-Useful Tools in the Battle against Cancer.
    Rodriguez SMB; Staicu GA; Sevastre AS; Baloi C; Ciubotaru V; Dricu A; Tataranu LG
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies].
    Turpin A; Sharif A; Stoven L; Blond S; Maurage CA; Le Rhun É
    Bull Cancer; 2015 Jan; 102(1):24-33. PubMed ID: 25609493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.